+1803294983432
customer.service@microbix.com
Respiratory Antigen Products
Extensive respiratory antigen panels for test innovation and development.
Setting the Gold Standard for Infectious Disease Diagnostic Standards
Decades of Trusted Quality
For almost three decades, our antigens have been of the highest reliability and quality for diagnostic companies worldwide.
Enhanced Precision
Our antigen products are excellent positive quality controls for diagnostics assays.
Comprehensive Coverage
Our extensive respiratory antigen panels fit any level of immunoassay you require.
Download Our Full Product Catalogue
Products
| Product Name | Catalogue Number | Description |
| Adenovirus, Grade 2 | EL-15-02 | Description: Native adenovirus antigen preparation contains a high concentration of virus and viral components as well as some cellular material in MEM. Strain: Adenoid 6 Buffer: MEM
|
| RSV | EL-07-03 | Description: Native RSV antigen preparation contains a high concentration of virus and viral components as well as some cellular material in HEPES + Magnesium Sulphate. Strain: Long Buffer: HEPES + Magnesium Sulphate
|
| Parainfluenza 2, Grade 2 | EL-09-02 | Description: Native Parainfluenza 2 virus antigen preparation contains a high contains a high concentration of virus and virus components as well as some cellular material suspended in Tissue Culture Media. Strain: Greer Buffer: Tissue Culture Media
|
| Parainfluenza 3, Grade 2 | EL-10-02 | Description: The resulting antigen preparation contains a high concentration of virus and virus components as well as some cellular material suspended in Tissue Culture Media. Strain: C243 Buffer: Tissue Culture Media
|
| Mycoplasma pneumoniae, Grade 2 | EL-11-02 | Description: Native mycoplasma pneumoniae antigen preparation contains soluble Mycoplasma components in PBS. Strain: FH Buffer: PBS
|
| Influenza A, Grade 2 | EL-13-02 | Description: Native influenza A virus preparation contains a high concentration of viral antigens as well as some egg proteins (allantoic fluid). Strain: Influenza A/New Caledonia/20/99 (/H1N1) Buffer: PBS
|
| Influenza A H3N2 | EL-13-03 | Description: Native influenza A virus preparation contains a high concentration of viral antigens as well as some egg proteins (allantoic fluid). Strain: H3N2 Subtype Buffer: PBS
|
| Influenza B | EL-14-03 | Description: Influenza B native antigen is derived from semi-purified cell culture lysate with a high titre of Influenza B particles. Cells were infected with the Influenza B/Hong Kong 5/72 strain. Strain: Hong Kong 5/72 Buffer: EMEM
|
| Chlamydophila (Chlamydia) pneumoniae | EL-46-02 | Description: Native C.(Chlamydia) pneumoniae preparation contains a high concentration of the bacteria suspended in SPG buffer. Strain: CWL-029 Buffer: SPG buffer
|
Frequently Asked Questions
Which respiratory viruses or pathogens do your respiratory antigens cover?
Our respiratory antigen products are appropriate for the qualitative detection of respiratory and influenza viruses including adenovirus Grade 2, respiratory syncytial virus (RSV), parainfluenza 2 Grade 2 and 3 Grade 2, mycoplasma pneumoniae Grade 2, influenza A Grade 2, influenza A H3N2, influenza B, chlamydophila pneumoniae.
Are your respiratory antigens available in different formats?
All antigen products are produced in liquid formulations. Depending on the product type, they can be ordered in 1mL, 10mL, 50mL, or 100mL.
Are your respiratory antigens suitable for diagnostic purposes or research applications?
Our respiratory antigens are applicable for research applications or further manufacturing use.
What is the source and purity of your respiratory antigens?
Our respiratory antigen products are derived from natural sources.
What is the shelf life of your respiratory antigens?
The shelf life of our respiratory antigen controls is two years from the shipping date.
Testimonials
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
Learn more about how our clients worldwide use Microbix’s product lines to enhance the way they do business.
We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.
Robert Martinez, VP of Business Development & Scientific Affairs
We were looking for a set of controls that fully covered the range of high-risk HPV types and Microbix is the only company to have such a portfolio. After an extensive evaluation process, we concluded the performance of Microbix QAPs are exactly what Ulisse needs and the interactions with their team are delightful.
Bruna Marini, COO
MDx testing for HPV improves cervical cancer screening by identifying those at-risk efficiently. Close monitoring of the entire HPV testing workflow is critical to realizing this healthcare goal and Microbix’s HPV QAPs have been selected to support the quality assessment monitoring of the molecular testing process, a vital part of BVO’s quality management system
Dr. Rob Schuurman, National Reference Officer for the Dutch Cervical Cancer Screening Program (BVO)
r-Biopharm is pleased that the program will be delivering world-class diagnostic testing to some of the most remote populations in Australia. It has been a privilege to work with the program’s operational team and Microbix to integrate the use of the best possible test and test-workflow controls into the program
Andreas Simons, Director, Project Management Clinical Diagnostics
We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality
Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.
We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
Alfie Zhen Fang, Buyer, Procurement
Your Trusted Respiratory Antigen Supplier
As diagnostic companies are continuously improving the speed and technology underlying their tests, they are reliant on Microbix’s high-quality respiratory antigens for test innovation and development.These antigens are inactivated for infectivity, not antigenicity, to ensure utmost user safety.
Our respiratory antigen product panel covers:
- Adenovirus Grade 2
- Respiratory syncytial virus (RSV)
- Parainfluenza virus 2 Grade 2 and 3 Grade 2
- Mycoplasma pneumoniae Grade 2
- Influenza A Grade 2
- Influenza A H3N2
- Influenza B
- Chlamydophila pneumoniae
Speak to a Respiratory Antigen Customer Service Representative
Let our knowledgeable experts help you secure your respiratory antigen products today.
News & Insights from Our Diagnostics Experts
Microbix & API Ensuring Flu Tests Can Detect H5N1 Strain
announces its intentions to broaden its platform capabilities to enable production of a wider range of test ingredients (“Antigens”) by using recombinant production technologies....
Microbix Expanding Addressable Market Share with Test Makers
announces its intentions to broaden its platform capabilities to enable production of a wider range of test ingredients (“Antigens”) by using recombinant production technologies....
Microbix Reports Record Product Sales for Q4 and Fiscal 2024
reports results for its fiscal year and fourth quarter ended September 30, 2024 (“2024” and “Q4”) with record revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ...